This provider averages 92 services per working day
Based on 138.4K total services over 6 years (250 working days/year). Learn about impossible service volumes →
This provider's $11.0M in total Medicare payments ranks in the 98th percentile of Ophthalmology providers nationally.
Averaging 92 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 228328% from 2018 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 13688% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2018 | $1.2K | $90.09 | 12.89x | $1.1K | $1.9K | 21 | 1 |
| 2019 | $523.06 | $210.71 | 2.48x | $312.35 | $260.9K | 1.2K | 13 |
| 2020 | $543.55 | $204.18 | 2.66x | $339.37 | $1.8M | 8.6K | 15 |
| 2021 | $559.19 | $217.53 | 2.57x | $341.66 | $2.1M | 9.5K | 15 |
| 2022 | $274.30 | $104.38 | 2.63x | $169.92 | $2.6M | 24.5K | 16 |
| 2023 | $123.27 | $45.70 | 2.70x | $77.57 | $4.3M | 94.6K | 15 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 8.2K | $5.9M | $717.89 | 1.50x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 97.8K | $2.8M | $28.82 | 1.80x |
| 67028 | Injection of drug into eye | 7.6K | $681.2K | $89.85 | 14.53x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 7.0K | $648.3K | $92.00 | 3.02x |
| 92134 | Imaging of retina | 9.4K | $283.8K | $30.29 | 4.19x |
| J9035 | Injection, bevacizumab, 10 mg | 3.1K | $178.8K | $58.01 | 1.54x |
| J3490 | Unclassified drugs | 54 | $102.1K | $1.9K | 1.79x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 1.6K | $92.0K | $58.04 | 3.25x |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 480 | $57.8K | $120.36 | 1.73x |
| J2778 | Injection, ranibizumab, 0.1 mg | 250 | $45.9K | $183.73 | 2.26x |
| 92014 | Established patient complete exam of visual system | 408 | $38.6K | $94.57 | 3.52x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 213 | $25.1K | $117.97 | 3.56x |
| 92004 | New patient complete exam of visual system | 225 | $24.5K | $108.83 | 3.58x |
| 67228 | Destruction of leaking blood vessels of retina using laser | 69 | $17.6K | $255.34 | 26.37x |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 1.4K | $14.8K | $10.85 | 10.19x |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | 147 | $8.6K | $58.27 | 3.84x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 87 | $6.8K | $78.41 | 5.43x |
| 92242 | Imaging of blood vessels in back of eye using fluorescein and indocyanine-green dye | 33 | $6.1K | $183.77 | 3.26x |
| 92250 | Photography of the retina | 179 | $5.2K | $29.01 | 7.15x |
| 92226 | Examination of eye by ophthalmoscope with retinal drawing | 75 | $1.5K | $19.66 | 5.65x |
This provider submits charges 2.65 times higher than what Medicare actually pays.
A markup ratio of 2.65x means for every $100 Medicare pays, this provider initially charges $265. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data